Literature DB >> 21789567

Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease.

Pollyana Feldhaus1, Daiane B Fraga, Fernando V Ghedim, Renata D De Luca, Thiago D Bruna, Matheus Heluany, Maria Paula Matos, Gabriela K Ferreira, Isabela C Jeremias, Claudia Heluany, Emilio L Streck, Alexandra I Zugno.   

Abstract

Alzheimer disease (AD) is a progressive neurodegenerative disease associated with cognitive impairment in multiple domains, such as memory and executive functions. Studies reveal damage in the electron transport chain of patients with AD, suggesting that this mitochondrial dysfunction plays an important role in the pathophysiology of the disease. Blood samples were taken from patients with AD (n = 20) and older subjects without dementia (n = 40) to evaluate the activity of complexes I, II, II-III, and IV of the mitochondrial respiratory chain in isolated lymphocytes. Results from the patient and control groups were compared. The activity of complexes II and IV was increased among patients compared to the control group. No significant difference was observed between controls who were not using psychotropic medication and patients. Our findings point out a mechanism of cellular compensation in which the mitochondrial respiratory chain requires an increase in electron transport to supply the energy needed for cellular functioning. Additional studies are needed to better clarify the mechanisms involved in the mitochondrial dynamics of AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789567     DOI: 10.1007/s11011-011-9253-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  58 in total

1.  [Suggestions for utilization of the mini-mental state examination in Brazil].

Authors:  Sonia M D Brucki; Ricardo Nitrini; Paulo Caramelli; Paulo H F Bertolucci; Ivan H Okamoto
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

Review 2.  Alzheimer's disease pathogenesis and therapeutic interventions.

Authors:  M S Parihar; Taruna Hemnani
Journal:  J Clin Neurosci       Date:  2004-06       Impact factor: 1.961

Review 3.  The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.

Authors:  Ekaterina Rogaeva
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

4.  Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation.

Authors:  C Strazielle; C Sturchler-Pierrat; M Staufenbiel; R Lalonde
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

6.  Mitochondrial alterations in Alzheimer's disease.

Authors:  Stavros J Baloyannis; Vassiliki Costa; Demetrios Michmizos
Journal:  Am J Alzheimers Dis Other Demen       Date:  2004 Mar-Apr       Impact factor: 2.035

7.  Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase.

Authors:  Esther Pérez-Gracia; Benjamín Torrejón-Escribano; Isidre Ferrer
Journal:  Acta Neuropathol       Date:  2008-07-16       Impact factor: 17.088

8.  [Mini mental state examination and the diagnosis of dementia in Brazil].

Authors:  O P Almeida
Journal:  Arq Neuropsiquiatr       Date:  1998-09       Impact factor: 1.420

9.  Enhanced levels of mitochondrial enzyme 17beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis.

Authors:  Zdena Kristofiková; Markéta Bocková; Katerina Hegnerová; Ales Bartos; Jan Klaschka; Jan Rícný; Daniela Rípová; Jirí Homola
Journal:  Mol Biosyst       Date:  2009-07-06

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  12 in total

Review 1.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

Review 2.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

3.  Genetic association of the cytochrome c oxidase-related genes with Alzheimer's disease in Han Chinese.

Authors:  Rui Bi; Wen Zhang; Deng-Feng Zhang; Min Xu; Yu Fan; Qiu-Xiang Hu; Hong-Yan Jiang; Liwen Tan; Tao Li; Yiru Fang; Chen Zhang; Yong-Gang Yao
Journal:  Neuropsychopharmacology       Date:  2018-07-06       Impact factor: 7.853

4.  Hesperidin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress in a mouse model of Alzheimer's disease.

Authors:  Dongmei Wang; Ling Liu; Xiaoying Zhu; Wenlan Wu; Yong Wang
Journal:  Cell Mol Neurobiol       Date:  2014-08-19       Impact factor: 5.046

Review 5.  Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.

Authors:  Jia Yao; Jamaica R Rettberg; Lauren P Klosinski; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Mol Aspects Med       Date:  2011-10-21

Review 6.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

Review 7.  Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Giusy Tassone; Arian Kola; Daniela Valensin; Cecilia Pozzi
Journal:  Life (Basel)       Date:  2021-04-24

Review 8.  The bad, the good, and the ugly about oxidative stress.

Authors:  Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Oxid Med Cell Longev       Date:  2012-04-26       Impact factor: 6.543

Review 9.  Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.

Authors:  Jana Hroudová; Namrata Singh; Zdeněk Fišar
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

10.  Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.

Authors:  A Delbarba; G Abate; C Prandelli; M Marziano; L Buizza; N Arce Varas; A Novelli; F Cuetos; C Martinez; C Lanni; M Memo; D Uberti
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.